• SIGN IN
  • GET HELP
  •  

    Webinar Details


    Event Type

    Live Online

    Date

    Friday, June 24, 2022

    Time

    2:00 PM - 3:00 PM ET

    Location

    PharmCon Webinar Studio (freeCE.com)

    Credits

    1 Contact Hour(s)

    Target Audience

    Pharmacist, Nurse

    Cost

    $30.00

    • Overview

      The guideline governing the management of blood cholesterol to reduce cardiovascular risk was revised at the end of 2018. At that time, several critical changes were made to the guideline, including the identification of high-risk and very high-risk factors, restructuring of patient groups in which to consider drug therapy, revised therapeutic targets, and incorporation of select non-statin drugs to the clinical armamentarium. Furthermore, two additional non-statin products have come to market since the guideline’s publication. It is imperative to disseminate these updates to healthcare practitioners, so that they can provide evidence-based, patient-centered care as members of an interdisciplinary team.


      Handouts

      Slide Document 21256L01_2pp.pdf
      Slide Document 21256L01_6pp.pdf





      Financial Support By

      PharmCon
    • Pharmacist

      Recognize the relationship between high cholesterol and atherosclerotic cardiovascular disease (ASCVD), including risk assessment
      Identify key recommendations from the 2018 Guideline on the Management of Blood Cholesterol
      Recognize the role of pharmacotherapy in dyslipidemia management to optimize pharmacotherapy plans and outcomes for patients with dyslipidemia

      Nurse

      Recognize the relationship between high cholesterol and atherosclerotic cardiovascular disease (ASCVD), including risk assessment
      Identify key recommendations from the 2018 Guideline on the Management of Blood Cholesterol
      Recognize the role of pharmacotherapy in dyslipidemia management to optimize pharmacotherapy plans and outcomes for patients with dyslipidemia
    • Repeat Presentation

      This presentation was last given on 6/24/2022 2:00 PM

      Future Airings

      Date Time
      Wednesday, July 27, 2022 10:30 AM View

    • Activity Type

      Application

      CE Broker

      20-881914

      Universal Activity Number

      Pharmacist 0798-0000-21-256-L01-P

      Nurse 0798-0000-21-256-L01-N

      ACPE PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

      PharmCon, Inc. is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

      In order to obtain a Statement of Credit, attendees must respond to all randomly-generated participation checks and complete a program evaluation. Attendees may immediately print their Statement of Credit or leave them stored on the website.


    HARDWARE REQUIREMENTS
    Windows 8.1
    Windows 10
    Apple Mac OS X 10.13 or higher
    iOS 10+
    Android 4.3+


    SOFTWARE REQUIREMENTS
    Google Chrome
    Mozilla Firefox

    Log in locally; do not log in using a VPN, cloud server, remote desktop, etc.


    NETWORK REQUIREMENTS
    Broadband Internet Connection:
    T1, Hi-speed DSL or Cable
    4G cellular connection
     
     

    This continuing education activity is held as copyright by PharmCon. Through this notice, PharmCon. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).




    Computer sharing is NOT permitted due to accreditation guidelines on activity monitoring. Credit is earned by one user per device.